𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tumor initiating cells in malignant gliomas: biology and implications for therapy

✍ Scribed by Costas G. Hadjipanayis; Erwin G. Van Meir

Publisher
Springer
Year
2009
Tongue
English
Weight
382 KB
Volume
87
Category
Article
ISSN
0946-2716

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Integrating tumor-initiating cells into
Integrating tumor-initiating cells into the paradigm for melanoma targeted therapy
✍ Keiran S.M. Smalley; Meenhard Herlyn πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 144 KB πŸ‘ 1 views

## Abstract There is growing evidence to suggest that not all cancer cells have similar levels of malignant potential and that tumor progression may be driven by specialized sub‐sets of β€œtumor initiating” cells. It is likely that as tumor initiating cells have lower proliferation rates and enhanced

Quantitative analysis of mitotic Olig2 c
Quantitative analysis of mitotic Olig2 cells in adult human brain and gliomas: Implications for glioma histogenesis and biology
✍ Wootack Rhee; Sutapa Ray; Hideaki Yokoo; Megan E. Hoane; Chong C. Lee; Andrei M. πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 728 KB

## Abstract The capacity of adult human glial progenitor cells (AGPs), to proliferate and undergo multipotent differentiation, positions them as ideal candidate cells of origin for human gliomas. To investigate this potential role we identified AGPs as mitotically active Olig2 cells in nonneoplasti

Vaccination with tumor cell lysate-pulse
Vaccination with tumor cell lysate-pulsed dendritic cells augments the effect of IFN-Ξ² gene therapy for malignant glioma in an experimental mouse intracranial glioma
✍ Ryuta Saito; Masaaki Mizuno; Norimoto Nakahara; Takaya Tsuno; Toshihiro Kumabe; πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 372 KB πŸ‘ 1 views

## Abstract Interferon‐β (IFN‐β) has been used as an antitumor drug against human glioma, melanoma and medulloblastoma since the 1980s. Recently, we developed a new gene therapy using the __IFN__‐β gene against malignant gliomas and then began clinical trials in 2000. Since stimulation of immune sy